Assessment of Risk Perception of COVID-19 Post Vaccination amongst the General Population of Riyadh Region
Abstract
:1. Introduction
2. Methods
2.1. Study Design
2.2. Pre-Testing
2.3. Survey Administration
2.4. Questionnaire
2.5. Sample Size Computation
2.6. Data Analyses
3. Results
4. Discussion
5. Conclusions/Recommendations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Rodriguez-Morales, A.J.; Bonilla-Aldana, D.K.; Balbin-Ramon, G.J.; Rabaan, A.A.; Sah, R.; Paniz-Mondolfi, A.; Pagliano, P.; Esposito, S. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic. Le Infez. Med. 2020, 28, 3–5. [Google Scholar]
- World Health Organization. Timeline of WHO’s Response to COVID-19; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Li, H.; Liu, S.M.; Yu, X.H.; Tang, S.L.; Tang, C.K. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int. J. Antimicrob. Agents 2020, 55, 105951. [Google Scholar] [CrossRef]
- Alimohamadi, Y.; Sepandi, M.; Taghdir, M.; Hosamirudsari, H. Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis. J. Prev. Med. Hyg. 2020, 61, E304–E312. [Google Scholar]
- Shereen, M.A.; Khan, S.; Kazmi, A.; Bashir, N.; Siddique, R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020, 24, 91–98. [Google Scholar] [CrossRef]
- van Doremalen, N.; Bushmaker, T.; Morris, D.H.; Holbrook, M.G.; Gamble, A.; Williamson, B.N.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Gerber, S.I.; et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N. Engl. J. Med. 2020, 382, 1564–1567. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. World Health Organization Coronavirus Disease (COVID-19) Dashboard; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Ebrahim, S.H.; Memish, Z.A. Saudi Arabia’s drastic measures to curb the COVID-19 outbreak: Temporary suspension of the Umrah pilgrimage. J. Travel Med. 2020, 27, taaa029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Tawfiq, J.A.; Memish, Z.A. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: Prevention and therapeutic strategies. Int. J. Antimicrob. Agents 2020, 55, 105968. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.; Alahmari, A.; Almuzaini, Y.; Alturki, N.; Aburas, A.; Alamri, F.A.; Albagami, M.; Alzaid, M.; Alharbi, T.; Alomar, R.; et al. The role of digital technology in responding to COVID-19 pandemic: Saudi Arabia’s experience. Risk Manag. Healthc. Policy 2021, 14, 3923. [Google Scholar] [CrossRef] [PubMed]
- Fiorino, S.; Tateo, F.; Biase, D.; Gallo, C.G.; Orlandi, P.E.; Corazza, I.; Budriesi, R.; Micucci, M.; Visani, M.; Loggi, E.; et al. SARS-CoV-2: Lessons from both the history of medicine and from the biological behavior of other well-known viruses. Future Microbiol. 2021, 16, 1105–1133. [Google Scholar] [CrossRef] [PubMed]
- Aw, J.; Seah, S.S.Y.; Seng, B.J.J.; Low, L.L. COVID-19-Related Vaccine Hesitancy among Community Hospitals’ Healthcare Workers in Singapore. Vaccines 2022, 10, 537. [Google Scholar] [CrossRef]
- Wright, L.; Steptoe, A.; Mak, H.W.; Fancourt, D. Do people reduce compliance with COVID-19 guidelines following vaccination? A longitudinal analysis of matched UK adults. J. Epidemiol. Community Health 2021, 76, 109–115. [Google Scholar] [CrossRef]
- Brug, J.; Aro, A.R.; Oenema, A.; de Zwart, O.; Richardus, J.H.; Bishop, G.D. SARS Risk Perception, Knowledge, Precautions, and Information Sources, the Netherlands. Emerg. Infect. Dis. 2004, 8, 1486–1489. [Google Scholar] [CrossRef]
- Freeman, D.; Loe, B.S.; Chadwick, A.; Vaccari, C.; Waite, F.; Rosebrock, L.; Jenner, L.; Petit, A.; Lewandowsky, S.; Vanderslott, S.; et al. COVID-19 vaccine hesitancy in the UK: The Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol. Med. 2022, 52, 3127–3141. [Google Scholar] [CrossRef] [PubMed]
- Shahin, M.A.; Hussien, R.M. Risk perception regarding the COVID-19 outbreak among the general population: A comparative Middle East survey. Middle East Curr. Psychiatry 2020, 27, 71. [Google Scholar] [CrossRef]
- Alsaif, B.; Elhassan, N.E.E.; Itumalla, R.; Ali, K.E.; Alzain, M.A. Assessing the Level of Awareness of COVID-19 and Prevalence of General Anxiety Disorder among the Hail Community, Kingdom of Saudi Arabia. Int. J. Environ. Res. Public Health 2021, 18, 7035. [Google Scholar] [CrossRef] [PubMed]
- Mohamed, N.A.; Solehan, H.M.; Mohd Rani, M.D.; Ithnin, M.; Che Isahak, C.I. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey. PLoS ONE 2021, 16, e0256110. [Google Scholar] [CrossRef]
- Alzahrani, S.H.; Baig, M.; Alrabia, M.W.; Algethami, M.R.; Alhamdan, M.M.; Alhakamy, N.A.; Asfour, H.Z.; Ahmad, T. Attitudes toward the SARS-CoV-2 vaccine: Results from the Saudi Residents’ Intention to Get Vaccinated against COVID-19 (SRIGVAC) study. Vaccines 2021, 9, 798. [Google Scholar] [CrossRef] [PubMed]
- Jaber, R.M.; Mafrachi, B.; Al-Ani, A.; Shkara, M. Awareness and perception of COVID-19 among the general population: A Middle Eastern survey. PLoS ONE 2021, 16, e0250461. [Google Scholar] [CrossRef] [PubMed]
- Siddiqui, A.A.; Alshammary, F.; Amin, J.; Rathore, H.A.; Hassan, I.; Ilyas, M.; Alam, M.K. Knowledge and practice regarding prevention of COVID-19 among the Saudi Arabian population. Work 2020, 66, 767–775. [Google Scholar] [CrossRef] [PubMed]
Item | Response | Gender, n (%) | Total | |
---|---|---|---|---|
Female | Male | |||
Age | 18–24 | 293 (29.1) | 54 (5.4) | 347 (34.4) |
25–31 | 58 (5.7) | 19 (1.9) | 77 (7.6) | |
32–38 | 76 (7.5) | 14 (1.4) | 90 (8.9) | |
39–45 | 108 (10.7) | 17 (1.7) | 125 (12.4) | |
46–52 | 128 (12.7) | 33 (3.3) | 161 (15.9) | |
53–59 | 81 (8.04) | 34 (3.4) | 115 (11.4) | |
60 and above | 61 (6.05) | 32 (3.2) | 93 (9.2) | |
Nationality | Saudi | 789 (79.2) | 196 (19.4) | 994 (98.6) |
Non-Saudi | 7(0.7) | 7(0.7) | 14 (1.4) | |
Marital Status | Single | 327 (32.4) | 72 (7.1) | 399 (39.6) |
Married | 430 (42.7) | 128 (12.7) | 558 (55.4) | |
Widowed | 26 (2.6) | 1 (0.1) | 27 (2.7) | |
Divorced | 22 (2.2) | 2 (0.2) | 24 (2.4) | |
Parental Status | Have children | 420 (41.7) | 120 (11.9) | 540 (53.6) |
Do not have children | 110 (10.9) | 18 (1.8) | 128 (12.7) | |
The question is not applicable to me | 268 (26.6) | 61 (6.05) | 329 (32.6) | |
Rather not to answer | 7 (0.7) | 4 (0.4) | 11 (0.9) | |
Highest level of education | Elementary School | 4 (0.4) | 0 | 4 (0.4) |
Middle School | 15 (1.5) | 9 (0.9) | 24 (2.4) | |
High School | 253 (25.1) | 35 (3.5) | 288 (28.6) | |
University bachelor | 465 (46.1) | 100 (9.9) | 565 (56.1) | |
University Masters | 44 (4.4) | 41 (4.1) | 85 (8.4) | |
University PhDs or equivalent | 9 (0.9) | 16 (1.6) | 25 (2.5) | |
The question is not applicable to me | 15 (1.5) | 2 (0.2) | 17 (1.69) | |
Employment Status | Student | 284 (28.2) | 53 (5.3) | 337 (33.4) |
Full time job | 216 (21.4) | 81 (8.04) | 297 (29.5) | |
Part time job | 26 (2.6) | 3 (0.3) | 29 (2.9) | |
Self empolyed | 9 (0.9) | 18 (1.8) | 27 (2.7) | |
The question is not applicable to me | 270 (26.8) | 48 (4.7) | 318 (31.5) | |
Total household income | Less than 1333$ | 27 (2.7) | 5 (0.5) | 32 (3.2) |
1334–2666$ | 112 (11.1) | 7 (0.7) | 119 (11.8) | |
2667–5333$ | 155 (15.4) | 43 (4.3) | 198 (19.6) | |
5334–7999$ | 118 (11.7) | 41 (4.1) | 159 (15.8) | |
8000–10,666$ | 52 (5.1) | 18 (1.8) | 70 (6.9) | |
10,667$ and more | 83 (8.2) | 46 (6.5) | 129 (12.8) | |
Rather not to disclose | 258 (25.6) | 43 (4.3) | 301 (29.9) |
Item | Response | n | % |
---|---|---|---|
Do you believe that COVID-19 exists | Yes | 975 | 96.5% |
No | 35 | 3.5% | |
What is the main reason for your willingness to receive the COVID-19 vaccine | To protect myself/my family from infection | 869 | 86% |
To meet the requirements of work policies | 113 | 11.2% | |
To receive a permission to travel (vaccine passport) | 28 | 2.8% | |
I have worries about getting COVID-19 infection after receiving the vaccine | Sometimes | 374 | 37% |
Occasional | 238 | 23.6% | |
Never | 198 | 19.6% | |
Most of the time | 112 | 11.1% | |
Always | 88 | 8.7% | |
After receiving COVID-19 vaccine, adequate immunity against COVID-19 infection is obtained | High probability | 368 | 36% |
Average probability | 354 | 35% | |
Very high probability | 158 | 15.6% | |
High Not getting enough immunity | 76 | 7% | |
Low propability | 54 | 5.4% | |
My risk perception towards COVID-19 has increased in comparison to before I received the COVID-19 vaccine | My perception hasn’t changed | 305 | 30.2% |
High degree | 248 | 24.6% | |
Moderate degree | 218 | 21.6% | |
To a very high degree | 179 | 17.7% | |
Low degree | 60 | 5.9% |
Item | Response | n | % |
---|---|---|---|
I continue to take precautions after receiving COVID-19 vaccine | Never | 15 | 1.5% |
Occasional | 31 | 3.1% | |
Sometimes | 179 | 17.7% | |
Most of the time | 318 | 31.5% | |
Always | 467 | 46.2% | |
You might be infected with Coronavirus (COVID-19) in the future if you do not take any preventive measures | Improbable | 10 | 1% |
Weakly probable | 47 | 4.7% | |
Moderately likely | 210 | 20.8% | |
Very likely | 381 | 37.7% | |
Extremely likely | 362 | 35.8% | |
Frequent hand hygiene helps to prevent Coronavirus (COVID-19) | Never | 6 | 0.6% |
Occasional | 14 | 1.4% | |
Sometimes | 74 | 7.3% | |
Most of the time | 275 | 27.2% | |
Always | 641 | 63.5% | |
Wearing masks help to prevent Coronavirus (COVID-19) | Never | 5 | 0.5% |
Occasional | 11 | 1.1% | |
Sometimes | 84 | 8.3% | |
Most of the time | 308 | 30.5% | |
Always | 602 | 59.6% | |
Keeping social distancing helps to prevent Coronavirus (COVID-19) | Never | 5 | 0.5% |
Occasional | 16 | 1.6% | |
Sometimes | 83 | 8.2% | |
Most of the time | 305 | 30.2% | |
Always | 601 | 59.5% |
Item | Response | Mean ± SD | p-Value |
---|---|---|---|
Age | 18–24 | 14.6 ± 4.3 | 0.008 * |
25–31 | 14.2 ± 4.7 | ||
32–38 | 13.5 ± 4.6 | ||
39–45 | 14.5 ± 4.8 | ||
46–52 | 13.4 ± 5.1 | ||
53–59 | 15.4 ± 4.1 | ||
60 and above | 14.7 ± 5.3 | ||
Gender | Female | 14.4 ± 4.5 | 0.853 |
Male | 14.4 ± 5.1 | ||
Nationality | Saudi | 14.4 ± 4.6 | 0.410 |
Non-Saudi | 13.4 ± 5.1 | ||
Marital Status | Single | 14.6 ± 4.5 | 0.363 |
Married | 14.2 ± 4.8 | ||
Widowed | 15.2 ± 5.1 | ||
Divorced | 15.1 ± 4.2 | ||
Parental Status | Have children | 14.2 ± 4.9 | 0.469 |
Do not have children | 14.3 ± 4.4 | ||
The question is not applicable to me | 14.7 ± 4.5 | ||
Rather not to answer | 13.3 ± 3.9 | ||
Highest level of education | Elementary School | 18.2 ± 1.5 | 0.264 |
Middle School | 14.6 ± 14.6 | ||
High School | 14.4 ± 4.5 | ||
University bachelor | 14.3 ± 4.6 | ||
University Masters | 13.7 ± 5.1 | ||
University PhDs or equivalent | 15.7 ± 5.0 | ||
Employment Status | Student | 14.6 ± 4.4 | 0.682 |
Full time job | 14.4 ± 4.8 | ||
Part time job | 14.2 ± 4.7 | ||
Self empolyed | 13.9 ± 6.2 | ||
Total household income | Less than 1333$ | 15.5 ± 4.6 | 0.399 |
1334–2666$ | 14.1 ± 4.5 | ||
2667–5333$ | 14.6 ± 4.4 | ||
5334–7999$ | 14.8 ± 5.02 | ||
8000–10,666$ | 14.04 ± 4.6 | ||
10,667$ and more | 13.8 ± 4.7 | ||
Rather not to disclose | 14.2 ± 4.7 |
Mean ± SD | |
---|---|
Female | |
18–24 | 14.5 ± 4.3 |
25–31 | 14.2 ± 4.3 |
32–38 | 13.5 ± 4.7 |
39–45 | 14.9 ± 4.8 |
46–52 | 13.6 ± 5.01 |
53–59 | 15.1 ± 3.9 |
60 and above | 14.8 ± 4.9 |
Male | |
18–24 | 15.3 ± 4.3 |
25–31 | 14.4 ± 5.9 |
32–38 | 13.8 ± 4.5 |
39–45 | 12.1 ± 4.5 |
46–52 | 12.7 ± 5.4 |
53–59 | 16.2 ± 4.5 |
60 and above | 14.4 ± 6.1 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Al-Shouli, S.T.; AlAfaleq, N.O.; Almansour, M.; Alsadhan, M.; Alsalem, N.; Alqahtani, M.; Aldahash, N.; Almazyad, L.; Alhazmi, S.; Aljerian, K. Assessment of Risk Perception of COVID-19 Post Vaccination amongst the General Population of Riyadh Region. Vaccines 2023, 11, 1276. https://doi.org/10.3390/vaccines11071276
Al-Shouli ST, AlAfaleq NO, Almansour M, Alsadhan M, Alsalem N, Alqahtani M, Aldahash N, Almazyad L, Alhazmi S, Aljerian K. Assessment of Risk Perception of COVID-19 Post Vaccination amongst the General Population of Riyadh Region. Vaccines. 2023; 11(7):1276. https://doi.org/10.3390/vaccines11071276
Chicago/Turabian StyleAl-Shouli, Samia T., Nouf O. AlAfaleq, Mohammed Almansour, Munira Alsadhan, Norah Alsalem, Maha Alqahtani, Norah Aldahash, Leena Almazyad, Sadeem Alhazmi, and Khaldoon Aljerian. 2023. "Assessment of Risk Perception of COVID-19 Post Vaccination amongst the General Population of Riyadh Region" Vaccines 11, no. 7: 1276. https://doi.org/10.3390/vaccines11071276
APA StyleAl-Shouli, S. T., AlAfaleq, N. O., Almansour, M., Alsadhan, M., Alsalem, N., Alqahtani, M., Aldahash, N., Almazyad, L., Alhazmi, S., & Aljerian, K. (2023). Assessment of Risk Perception of COVID-19 Post Vaccination amongst the General Population of Riyadh Region. Vaccines, 11(7), 1276. https://doi.org/10.3390/vaccines11071276